Skip to main navigation Skip to search Skip to main content

COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine

  • Muheon Shin
  • , Chae Young Hyun
  • , Yoon Ho Choi
  • , Joon Young Choi
  • , Kyung Han Lee
  • , Young Seok Cho

Research output: Contribution to journal › Article › peer-review

Abstract

Purpose This study investigated 18F-FDG PET/CT features of adenovirus-vectored vaccination against COVID-19 in healthy subjects. Patients and Methods Thirty-one health care workers had been vaccinated Vaxzevria and underwent FDG PET/CT as an optional test for a cancer screening program. Size and FDG uptake of the hypermetabolic lymph nodes were measured. Uptake value of spleen was also measured with liver for comparison. Results All examinees who underwent FDG PET/CT within 14 days' interval showed hypermetabolic lymphadenopathies ipsilateral to vaccine injection. All examinees with hypermetabolic lymphadenopathy had simultaneous muscular uptakes until 23 days' interval. Among 12 examinees who underwent FDG PET/CT more than 15 days after vaccination, only 3 male examinees did not show hypermetabolism in the axillary lymph nodes. There was no female examinee with negative hypermetabolic lymphadenopathy until 29 days after vaccination. Conclusions Hypermetabolic reactive lymphadenopathy in the ipsilateral axillary area with or without supraclavicular area is most likely to occur in a healthy person with recent adenovirus-vectored COVID-19 vaccination on FDG PET/CT.

Original languageEnglish (US)
Pages (from-to)814-819
Number of pages6
JournalClinical nuclear medicine
Volume46
Issue number10
DOIs
StatePublished - Oct 1 2021
Externally publishedYes

Keywords

  • AstraZeneca
  • axillary lymph node
  • COVID-19
  • FDG PET/CT
  • lymphadenopathy
  • vaccination
  • Vaxzevria

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine'. Together they form a unique fingerprint.

Cite this